Literature DB >> 20870020

Monitoring of Bordetella isolates circulating in Saint Petersburg, Russia between 2001 and 2009.

Natalia Kurova1, Elisabeth Njamkepo, Delphine Brun, Galina Tseneva, Nicole Guiso.   

Abstract

Bordetella isolates in the Saint Petersburg region have been monitored since 1998. Over the past ten years, concomitant with the increase in pertussis whole-cell vaccine coverage, the incidence of whooping cough has decreased. However, this decrease exists only for Bordetella pertussis infections, as the incidence of Bordetella parapertussis confirmed cases has remained stable, suggesting that pertussis-vaccine-induced immunity is not protective against parapertussis, as expected. B. pertussis and B. parapertussis clinical isolates were analyzed using serotyping, immunoblotting, pulsed-field gel electrophoresis of chromosomal DNA (after digestion with XbaI) and sequencing of virulence genes. The bacterial population is now similar to that observed in other European countries.
Copyright © 2010 Institut Pasteur. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20870020     DOI: 10.1016/j.resmic.2010.09.013

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  9 in total

1.  Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use.

Authors:  Ewa Mosiej; Ewa Augustynowicz; Monika Zawadka; Waldemar Dabrowski; Anna Lutyńska
Journal:  J Clin Microbiol       Date:  2011-02-09       Impact factor: 5.948

2.  Bordetella parapertussis survives inside human macrophages in lipid raft-enriched phagosomes.

Authors:  Juan Gorgojo; Eric T Harvill; Maria Eugenia Rodríguez
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

3.  Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen.

Authors:  Juan Gorgojo; Yanina Lamberti; Hugo Valdez; Eric T Harvill; Maria Eugenia Rodríguez
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

4.  Incidence and factors predicting whooping cough due to parapertussis diagnosis among patients referred to general practitioners, Poland, 2009-2011.

Authors:  R Tomialoic; P Stefanoff; I Paradowska-Stankiewicz; A Zasada; M Sadkowska-Todys
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-31       Impact factor: 3.267

5.  Bordetella parapertussis outbreak in Bisham, Pakistan in 2009-2010: fallout of the 9/11 syndrome.

Authors:  S Javed; F Said; S A M A S Eqani; H Bokhari
Journal:  Epidemiol Infect       Date:  2015-01-13       Impact factor: 4.434

6.  Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.

Authors:  Connie Lam; Sophie Octavia; Lawrence Ricafort; Vitali Sintchenko; Gwendolyn L Gilbert; Nicholas Wood; Peter McIntyre; Helen Marshall; Nicole Guiso; Anthony D Keil; Andrew Lawrence; Jenny Robson; Geoff Hogg; Ruiting Lan
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883

7.  Comparative genomics of whole-cell pertussis vaccine strains from India.

Authors:  Shweta Alai; Vikas C Ghattargi; Manish Gautam; Krunal Patel; Shrikant P Pawar; Dhiraj P Dhotre; Umesh Shaligram; Sunil Gairola
Journal:  BMC Genomics       Date:  2020-05-07       Impact factor: 3.969

8.  Fha Deficient Bordetella pertussis Isolates in Iran with 50 Years Whole Cell Pertussis Vaccination.

Authors:  Samaneh Saedi; Azadeh Safarchi; Faranak Tayebzadeh Moghadam; Siamak Heidarzadeh; Vajihe Sadat Nikbin; Fereshteh Shahcheraghi
Journal:  Iran J Public Health       Date:  2021-07       Impact factor: 1.429

9.  Prevalence and characterization of pertactin deficient Bordetella pertussis strains in Brazil, a whole-cell vaccine country.

Authors:  Daniela Leite; Carlos Henrique Camargo; Suely Sanae Kashino; Ricardo Polatto; Luciano Moura Martins; Juliana Cristina Pereira; Lucia Pawloski; Maria Lucia Tondella; Rosangela Siqueira de Oliveira; Lourdes Rehder de Andrade Vaz de Lima
Journal:  Vaccine X       Date:  2021-06-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.